Kenvue Inc.
KVUE
株式のランク
#663
Kenvue Inc. functions as a global leader in the consumer health sector. The... Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.
株価
$19.29
最終同期: 2026-10-20
時価総額
$37.05B
変化（1日）
2.23%
変化（1年）
29.20%
国
US
取引 Kenvue Inc. (KVUE)
カテゴリー
Consumer Defensive
Kenvue Inc.（KVUE）の発行済株式数
June 2026 時点の発行済株式数 1.92B
Kenvue Inc. の最新の財務報告および株価によると、現在の発行済株式数は 1.92B です。December 2023 の終わりには、同社は 1.85B 株の発行済株式 を有していました。発行済株式数は、通常、株式分割や自社株買いによって影響を受けます。
Kenvue Inc.（KVUE）の発行済株式数の履歴（2019 ～ 2026）
各年末時点の発行済株式数
| 年 | 発行済株式数 | 変化 |
|---|---|---|
| 2026 (TTM) | 1.92B | 0.26% |
| 2024 | 1.92B | 3.58% |
| 2023 | 1.85B | -3.45% |
| 2022 | 1.91B | 1.37% |
| 2021 | 1.89B | 0.00% |
| 2020 | 1.89B | 0.00% |
| 2019 | 1.89B | 0.00% |
類似企業や競合他社の発行済株式数
| 企業 | 発行済株式数 | 差 | 国 |
|---|---|---|---|
| 2.42B | 26.17% |
US
|
|
| 533.97M | -72.19% |
FR
|
|
| 0.00 | -100.00% |
US
|
|
| 2.35B | 22.34% |
IN
|
|
| 362.30M | -81.13% |
US
|
